Company: CDT
Filing Date: 2025-02-05
Form Type: S-3
Source: 0001493152-25-005052
Chunk: 43

Company: CDT Equity Inc.
Filing Date: 2025-02-05
Form: S-3
Chunk 43
---
filed as Exhibit 10.1 to the Current Report on Form 8-K (File No. 001-41245) filed on December 17, 2024 and incorporated herein by reference).                                                                     |
| 23.1*   |     | Consent of Thompson Hine LLP (included in Exhibit 5.1)                                                                                                                                                                                                                                                                    |
| 23.2*   |     | Consent of Marcum LLP, Independent Registered Public Accounting Firm                                                                                                                                                                                                                                                      |
| 24.1    |     | Power of Attorney (included on signature page)                                                                                                                                                                                                                                                                            |
| 107*    |     | Filing Fee Table                                                                                                                                                                                                                                                                                                          |

*Filed herewith

| II-8 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Naples, State of Florida, on February 5, 2025.

| CONDUIT              
 PHARMACEUTICALS INC. |                   |
| By:                  | /s/               
 David Tapolczay   |
| Name:                | David             
 Tapolczay         |
| Title:               | Chief             
 Executive Officer |

| II-9 |

<div align='center'>POWER OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints David Tapolczay and/or James Bligh, as his true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment or